The analytical accuracy of the results of routine clinical chemistry m
easurements is contributed by a two-steps mechanism, involving transfe
rring trueness from a higher metrological and monitoring the time-stab
ility of trueness itself. In both operations, different materials are
used: however, accuracy in the routine assay of genuine patient sample
s has to be the end product of this overall process. To such an aim, t
he materials must show an intermethod behavior similar eo that of pati
ent sera, i.e., they have to show commutability. Definitions of commut
ability and methods for assessing such a property are mentioned. The f
ollowing aspects of lack of commutability of materials are then discus
sed: frequency; effects on the measured interlaboratory variability; a
nd effects on the recalibration of analytical systems. The causes givi
ng rise to lack of commutability are neither clear or easy to be shown
. Matrix effect is one of the main causes; also, differences in the ch
aracteristics of the component being measured are often responsible fo
r noncommutability of materials for enzyme activity measurements. Exam
ples of these two different situations are given. It is concluded that
, for an efficacious overall quality assurance process, either a set o
f minimally processed patient sera or commutable reference materials a
re to be used in the operations concerned with the control of trueness
. An additional alternative approach is based on the use of materials
with system-specific assigned values. Copyright (C) 1998 The Canadian
Society of Clinical Chemists.